BIOCONTROL LIMITED
Get an alert when BIOCONTROL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-04 (in 6mo)
Last made up 2025-10-21
Watchouts
Cash
—
Latest balance sheet
Net assets
-£5M
-1.8% vs 2023
Employees
—
Average over period
Profit before tax
—
Period ending 2024-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Notwithstanding net liabilities of £4,953,373, the directors consider the company to be a going concern as it has the financial support of its ultimate parent company, Armata Pharmaceuticals, Inc. ... The Group has incurred significant recurring losses from operations and negative operating cash flows since inception... This will not be sufficient to fund its operations for the next 12 months. Therefore there is substantial doubt as to the Group's and this Company's ability to continue as a going concern.
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £253,970 | -£88,221 | |
| Profit before tax | — | — | |
| Net profit | £253,970 | -£88,221 | |
| Cash | — | — | |
| Total assets less current liabilities | -£4,865,152 | -£4,953,373 | |
| Net assets | -£4,865,152 | -£4,953,373 | |
| Equity | -£4,865,152 | -£4,953,373 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -5.2% | 1.8% | |
| Current ratio | 0.00x | 0.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Bishop Fleming Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Notwithstanding net liabilities of £4,953,373, the directors consider the company to be a going concern as it has the financial support of its ultimate parent company, Armata Pharmaceuticals, Inc. ... The Group has incurred significant recurring losses from operations and negative operating cash flows since inception... This will not be sufficient to fund its operations for the next 12 months. Therefore there is substantial doubt as to the Group's and this Company's ability to continue as a going concern.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 34 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BIRX, Deborah, Dr | Director | 2023-07-10 | Apr 1956 | American |
| HAIMOVITZ, Jules | Director | 2021-06-07 | Dec 1950 | American |
Show 34 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BHARDWAJ, Ashok | Nominee Secretary | 1997-10-20 | 1997-10-20 |
| HURWITZ, Jonathan | Secretary | 1997-10-20 | 2001-10-31 |
| MILANEN, Tuula Kristiina | Secretary | 2008-04-16 | 2011-01-06 |
| POSTON, David | Secretary | 2011-01-06 | 2011-09-29 |
| SHEPPARD, Julian Mark | Secretary | 2001-10-31 | 2005-09-17 |
| WILLIAMS, Caroline Ann, Dr | Secretary | 2005-09-22 | 2008-04-16 |
| JAMES COWPER TRUSTEES LIMITED | Corporate Secretary | 2011-09-30 | 2024-05-23 |
| ANGGARD, Erik, Professor | Director | 2007-01-17 | 2011-01-06 |
| ANGGARD, Erik, Professor | Director | 2000-09-19 | 2005-01-08 |
| BLUNT JR, Frank Christopher | Director | 2003-12-22 | 2004-07-29 |
| BOSHER, David Earl | Director | 2015-12-01 | 2016-06-27 |
| BUTLER, Erin Lee Michelle | Director | 2022-07-01 | 2023-05-01 |
| CAPPABIANCA, Edward Charles | Director | 2011-01-06 | 2011-11-07 |
| CURNOCK-COOK, Jeremy Lawrence | Director | 2011-01-06 | 2020-12-08 |
| EVANS, Nigel James Forrester | Director | 2002-09-24 | 2011-01-06 |
| GRINT, Paul Charles Alexander, Dr. | Director | 2017-06-01 | 2020-10-05 |
| HAMILTON, Giles | Director | 2004-03-10 | 2005-09-21 |
| HARPER, David Richard, Dr | Director | 2008-04-16 | 2011-01-06 |
| HARPER, David Richard, Dr | Director | 1997-10-20 | 2005-01-28 |
| HURWITZ, Jonathan | Director | 1997-10-20 | 2001-10-31 |
| MARTIN, Steve Robert | Director | 2016-06-27 | 2022-06-30 |
| MCBRIDE, Martin | Director | 2005-11-30 | 2006-07-31 |
| MILLER, Martin William, Dr | Director | 2002-05-13 | 2004-04-30 |
| PATRICK, Todd Robert | Director | 2019-10-05 | 2022-11-16 |
| SALKA, Michael Scott | Director | 2015-12-01 | 2017-05-31 |
| SCOTT, David Vaughan | Director | 2007-10-18 | 2011-01-06 |
| SHEPPARD, Julian Mark | Director | 2001-08-02 | 2005-09-17 |
| SMITH, Philip Henry, Dr | Director | 2003-07-01 | 2005-10-19 |
| VARNUM, Brian | Director | 2021-08-02 | 2023-07-10 |
| WALKER, John Trevor, Professor | Director | 2003-01-27 | 2003-09-02 |
| WILLIAMS, Caroline Ann, Dr | Director | 2005-09-22 | 2013-06-26 |
| WREN, Brendan | Director | 2000-09-19 | 2003-09-02 |
| YOUNG, Philip Joseph | Director | 2011-11-07 | 2014-09-15 |
| BHARDWAJ CORPORATE SERVICES LIMITED | Corporate Nominee Director | 1997-10-20 | 1997-10-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Armata Pharmaceuticals Inc | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 247 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-10-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-23 | AD02 | address | Change sail address company with old address new address | |
| 2024-10-22 | CH01 | officers | Change person director company with change date | |
| 2024-10-22 | CH01 | officers | Change person director company with change date | |
| 2024-10-05 | AA | accounts | Accounts with accounts type full | |
| 2024-10-03 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-12-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-20 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-11-13 | AA | accounts | Accounts with accounts type full | |
| 2023-10-19 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-19 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-19 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-18 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-11-18 | AP01 | officers | Appoint person director company with name date | |
| 2022-11-18 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-18 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
-1.8%
-£4,865,152 -£4,953,373
-
Employees
—
Not reported
-
Operating profit
-134.7%
£253,970 -£88,221
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers